Fisher ER, Palekar AS, Redmond C, Barton B, Fisher B. Pathologic Findings from the National Surgical Adjuvant Breast Project (Protocol No. 4): VI. Invasive papillary cancer. Am J Clin Pathol. 1980;73(3):313–22. https://doi.org/10.1093/ajcp/73.3.313.
Article
CAS
PubMed
Google Scholar
Kim MJ, Gong G, Joo HJ, Ahn SH, Ro JY. Immunohistochemical and clinicopathologic characteristics of invasive ductal carcinoma of breast with micropapillary carcinoma component. Arch Pathol Lab Med. 2005;129(10):1277–82.
PubMed
Google Scholar
Chen AC, Paulino AC, Schwartz MR, Rodriguez AA, Bass BL, Chang JC, et al. Prognostic markers for invasive micropapillary carcinoma of the breast: a population-based analysis. Clin Breast Cancer. 2013;13(2):133–9.
Article
CAS
Google Scholar
Tavassoli FA, Devilee P. Pathology and genetics of tumours of the breast and female genital organs. New York: IARC; 2003.
Google Scholar
Yu JI, Choi DH, Huh SJ, Cho EY, Kim K, Chie EK, et al. Differences in prognostic factors and failure patterns between invasive micropapillary carcinoma and carcinoma with micropapillary component versus invasive ductal carcinoma of the breast: retrospective multicenter case–control study (KROG 13-06). Clin Breast Cancer. 2015;15(5):352–3.
Article
Google Scholar
Chen H, Ding A. Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast. Breast. 2015;24(6):723–31.
Article
Google Scholar
Shi WB, Yang LJ, Hu X, Zhou J, Zhang Q, Shao ZM. Clinico-pathological features and prognosis of invasive micropapillary carcinoma compared to invasive ductal carcinoma: a population-based study from China. PLoS ONE. 2014;9(6):e101390.
Article
Google Scholar
Cui ZQ, Feng JH, Zhao YJ. Clinicopathological features of invasive micropapillary carcinoma of the breast. Oncol Lett. 2015;9(3):1163–6. https://doi.org/10.3892/ol.2014.2806.
Article
PubMed
Google Scholar
Lerro CC, Robbins AS, Phillips JL, Stewart AK. Comparison of cases captured in the national cancer data base with those in population-based central cancer registries. Ann Surg Oncol. 2013;20(6):1759–65. https://doi.org/10.1245/s10434-013-2901-1.
Article
PubMed
Google Scholar
Haque W, Lewis GD, Verma V, Darcourt JG, Butler EB, Teh BS. The role of adjuvant chemotherapy in locally advanced bladder cancer. Acta Oncol (Madr). 2018;57(4):509–15. https://doi.org/10.1080/0284186X.2017.1415461.
Article
Google Scholar
Haque W, Verma V, Lewis GD, Lo SS, Butler EB, Teh BS. Utilization of radiotherapy and stereotactic body radiation therapy for renal cell cancer in the USA. Future Oncol. 2018;14(9):819–27. https://doi.org/10.2217/fon-2017-0536.
Article
CAS
PubMed
Google Scholar
Lewis GD, Haque W, Butler EB, Teh BS. Survival outcomes and patterns of management for anal adenocarcinoma. Ann Surg Oncol. 2019;26(5):1351–7. https://doi.org/10.1245/s10434-019-07202-4.
Article
PubMed
Google Scholar
Lewis GD, Dalwadi SM, Farach A, Butler EB, Teh BS. The role of adjuvant radiotherapy in the treatment of pleural mesothelioma. Ann Surg Oncol. 2019;26(6):1879–85. https://doi.org/10.1245/s10434-019-07235-9.
Article
PubMed
Google Scholar
Lewis GD, Haque W, Verma V, Butler EB, Teh BS. The role of adjuvant radiation therapy in locally advanced bladder cancer. Bl Cancer. 2018;4(2):205–13.
Article
Google Scholar
Chen AC, Paulino AC, Schwartz MR, Rodriguez AA, Bass BL, Chang JC, et al. Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast. Br J Cancer. 2014;111(3):619–22.
Article
CAS
Google Scholar
Clark GM, Osborne CK, McGuire WL. Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. J Clin Oncol. 1984;2(10):1102–9.
Article
CAS
Google Scholar
Osborne CK, Fisher E, Redmond C, Knight WA, Yochmowitz MG, McGuire WL. Estrogen receptor, a marker for human breast cancer differentiation and patient prognosis. Boston: Springer; 1982. p. 377–85. https://doi.org/10.1007/978-1-4615-7192-6_23.
Book
Google Scholar
Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL, et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol. 2008;26(14):2373–8. https://doi.org/10.1200/JCO.2007.14.4287.
Article
PubMed
Google Scholar
Haffty BG, Yang Q, Reiss M, Kearney T, Higgins SA, Weidhaas J, et al. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol. 2006;24(36):5652–7.
Article
Google Scholar
Zuo T, Zeng H, Li H, Liu S, Yang L, Xia C, et al. The influence of stage at diagnosis and molecular subtype on breast cancer patient survival: a hospital-based multi-center study. Chin J Cancer. 2017;36(1):84.
Article
Google Scholar
de la Rochefordière A, Campana F, Fenton J, Vilcoq JR, Fourquet A, Asselain B, et al. Age as prognostic factor in premenopausal breast carcinoma. Lancet. 1993;341(8852):1039–43.
Article
Google Scholar
Fredholm H, Magnusson K, Lindström LS, Garmo H, Fält SE, Lindman H, et al. Long-term outcome in young women with breast cancer: a population-based study. Breast Cancer Res Treat. 2016;160(1):131–43. https://doi.org/10.1007/s10549-016-3983-9.
Article
PubMed
PubMed Central
Google Scholar
Wong FY, Tham WY, Nei WL, Lim C, Miao H. Age exerts a continuous effect in the outcomes of Asian breast cancer patients treated with breast-conserving therapy. Cancer Commun (London, England). 2018;38(1):39.
Article
Google Scholar
Bonnier P, Romain S, Charpin C, Lejeune C, Tubiana N, Martin P-M, et al. Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features. Int J Cancer. 1995;62(2):138–44. https://doi.org/10.1002/ijc.2910620205.
Article
CAS
PubMed
Google Scholar
Sabiani L, Houvenaeghel G, Heinemann M, Reyal F, Classe JM, Cohen M, et al. Breast cancer in young women: pathologic features and molecular phenotype. Breast. 2016;29:109–16.
Article
Google Scholar
Liedtke C, Rody A, Gluz O, Baumann K, Beyer D, Kohls E-B, et al. The prognostic impact of age in different molecular subtypes of breast cancer. Breast Cancer Res Treat. 2015;152(3):667–73. https://doi.org/10.1007/s10549-015-3491-3.
Article
CAS
PubMed
Google Scholar
Griffiths RI, Gleeson ML, Valderas JM, Danese MD. Impact of undetected comorbidity on treatment and outcomes of breast cancer. Int J Breast Cancer. 2014;2014:970780.
Article
Google Scholar
Braithwaite D, Moore DH, Satariano WA, Kwan ML, Hiatt RA, Kroenke C, et al. Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomarkers Prev. 2012;21(7):1115–25.
Article
Google Scholar
Land LH, Dalton SO, Jørgensen TL, Ewertz M. Comorbidity and survival after early breast cancer: a review. Crit Rev Oncol Hematol. 2012;81(2):196–205.
Article
Google Scholar
Clarke M, Collins R, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087–106.
Article
CAS
Google Scholar
Overgaard M, Nielsen HM, Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol. 2007;82(3):247–53.
Article
Google Scholar
Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. JNCI J Natl Cancer Inst. 2005;97(2):116–26. https://doi.org/10.1093/jnci/djh297.
Article
PubMed
Google Scholar
Haffty BG, Mahmoud O. The evolution of regional nodal irradiation in breast cancer. Breast J. 2015;21(1):32–41. https://doi.org/10.1111/tbj.12351.
Article
PubMed
Google Scholar
Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, et al. Regional nodal irradiation in early-stage breast cancer. N Engl J Med. 2015;373(4):307–16. https://doi.org/10.1056/NEJMoa1415340.
Article
CAS
PubMed
PubMed Central
Google Scholar
Poortmans PM, Collette S, Kirkove C, Van Limbergen E, Budach V, Struikmans H, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015;373(4):317–27. https://doi.org/10.1056/NEJMoa1415369.
Article
CAS
PubMed
Google Scholar
EBCTCG (Early Breast Cancer Trialists’ Collaborative Group) P, McGale P, Taylor C, Correa C, Cutter D, Duane F, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet (London, England). 2014;383(9935):2127–35.
Article
Google Scholar
Walsh MM, Bleiweiss IJ. Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity. Hum Pathol. 2001;32(6):583–9.
Article
CAS
Google Scholar
Vingiani A, Maisonneuve P, Dell’Orto P, Farante G, Rotmensz N, Lissidini G, et al. The clinical relevance of micropapillary carcinoma of the breast: a case–control study. Histopathology. 2013;63(2):217–24. https://doi.org/10.1111/his.12147.
Article
PubMed
Google Scholar
Adrada B, Arribas E, Gilcrease M, Yang WT. Invasive micropapillary carcinoma of the breast: mammographic, sonographic, and MRI features. Am J Roentgenol. 2009;193(1):W58–63. https://doi.org/10.2214/AJR.08.1537.
Article
Google Scholar
Chen L, Fan Y, Lang R, Guo X, Sun Y, Cui L, et al. Breast carcinoma with micropapillary features: clinicopathologic study and long-term follow-up of 100 cases. Int J Surg Pathol. 2008;16(2):155–63. https://doi.org/10.1177/1066896907307047.
Article
CAS
PubMed
Google Scholar
De La Cruz C, Moriya T, Endoh M, Watanabe M, Takeyama J, Yang M, et al. Invasive micropapillary carcinoma of the breast: clinicopathological and immunohistochemical study. Pathol Int. 2004;54(2):90–6. https://doi.org/10.1111/j.1440-1827.2004.01590.x.
Article
PubMed
Google Scholar
Luna-Moré S, Casquero S, Pérez-Mellado A, Rius F, Weill B, Gornemann I. Importance of estrogen receptors for the behavior of invasive micropapillary carcinoma of the breast. Review of 68 cases with follow-up of 54. Pathol Res Pract. 2000;196(1):35–9.
Article
Google Scholar
Middleton LP, Tressera F, Sobel ME, Bryant BR, Alburquerque A, Grases P, et al. Infiltrating micropapillary carcinoma of the breast. Mod Pathol. 1999;12(5):499–504.
CAS
PubMed
Google Scholar
Nassar H, Wallis T, Andea A, Dey J, Adsay V, Visscher D. Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma. Mod Pathol. 2001;14(9):836–41.
Article
CAS
Google Scholar
Paterakos M, Watkin WG, Edgerton SM, Moore DH, Thor AD. Invasive micropapillary carcinoma of the breast: a prognostic study. Hum Pathol. 1999;30(12):1459–63.
Article
CAS
Google Scholar
Pettinato G, Manivel CJ, Panico L, Sparano L, Petrella G. Invasive micropapillary carcinoma of the breast. Am J Clin Pathol. 2004;121(6):857–66. https://doi.org/10.1309/XTJ7VHB49UD78X60.
Article
PubMed
Google Scholar
Yamaguchi R, Tanaka M, Kondo K, Yokoyama T, Kaneko Y, Yamaguchi M, et al. Characteristic morphology of invasive micropapillary carcinoma of the breast: an immunohistochemical analysis. Jpn J Clin Oncol. 2010;40(8):781–7.
Article
Google Scholar
Zekioglu O, Erhan Y, Ciris M, Bayramoglu H, Ozdemir N. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma. Histopathology. 2004;44(1):18–23. https://doi.org/10.1111/j.1365-2559.2004.01757.x.
Article
CAS
PubMed
Google Scholar